Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2007-11-29Clinical Trial Update: Effects of Lumiracoxib and Ibuprofen on Blood Pressure and Urinary Eicosanoid Excretion in Osteoarthritis Patients With Controlled Hypertension [Phase 4]
A Phase 4 clinical trial comparing the effects of lumiracoxib and ibuprofen on blood pressure and urinary eicosanoid excretion in patients w…
-
CLINICAL_TRIALS trial_result · 2007-11-29Clinical Trial Update: Effects of Aliskiren, Irbesartan, and the Combination in Hypertensive Patients With Type 2 Diabetes and Diabetic Nephropathy [Phase 1, Phase 2]
This report covers a Phase 1/Phase 2 clinical trial evaluating aliskiren, irbesartan, and their combination in hypertensive patients with ty…
-
CLINICAL_TRIALS trial_result · 2007-11-28Clinical Trial Update: Evaluation of Efficacy and Safety of the Dosage Adjustment of Aprovel® (Irbesartan) in Hypertensive Outpatients in Current Clinical Practice [Phase 4]
Phase 4 clinical trial evaluating the efficacy and safety of dosage adjustments of irbesartan (Aprovel) in hypertensive outpatients in real-…
-
CLINICAL_TRIALS research · 2007-11-28Clinical Trial Update: Collection of Blood and Urine Specimens From Volunteers Utilizing Health Examination Services
A clinical trial update from National Taiwan University Hospital describes collecting blood and urine specimens from volunteers using health…
-
CLINICAL_TRIALS trial_result · 2007-11-27Clinical Trial Update: The Efficacy and Safety of Irbesartan 150/12.5 mg and 300/25 mg in Patients With Mild Hypertension [Phase 4]
Phase 4 trial evaluating the efficacy and safety of irbesartan at 150/12.5 mg and 300/25 mg in patients with mild hypertension.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2007-11-26Clinical Trial Update: Randomized, Parallel, Comparison, Double-Blind Efficacy & Safety Study of APROVEL Versus Placebo in Chinese Patients With Hypertensive Type II Diabetic Patients With Microalbuminuria [Phase 3]
This document describes a Phase 3 randomized, double-blind trial comparing APROVEL to placebo in Chinese patients with hypertension and type…
-
CLINICAL_TRIALS research · 2007-11-22Clinical Trial Update: RIAT Registry: Reason for Not Intensifying Antihypertensive Treatment
A completed RIAT Registry update explains the reasons for not intensifying antihypertensive treatment in hypertension.
-
CLINICAL_TRIALS research · 2007-11-20Clinical Trial Update: PPARgamma Activation by Losartan in Hypertensive Patients: The Importance of Losartan-Metabolites
This document reports a clinical trial update evaluating whether losartan activates PPARgamma in hypertensive patients and discusses the pot…
-
CLINICAL_TRIALS research · 2007-11-19Clinical Trial Update: Is Orthostatic Hypotension Associated With Nondipping Hypertension
Clinical trial update examining whether orthostatic hypotension is associated with nondipping hypertension.
-
FDA approval · 2007-11-16FDA Approved: BENICAR HCT — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for BENICAR HCT (olmesartan medoxomil-hydrochlorothiazide) from Cosette Pharmaceuticals, Inc.
-
FDA approval · 2007-11-16FDA Approved: AVALIDE — Supplemental Application (Sanofi-Aventis U.S. LLC)
The FDA approved a supplemental application for AVALIDE (irbesartan and hydrochlorothiazide) submitted by Sanofi-Aventis U.S. LLC. This acti…
-
CLINICAL_TRIALS trial_result · 2007-11-14Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Daglutril Compared to Placebo on Top of Losartan in Type 2 Diabetics With Overt Nephropathy and Well Controlled Hypertension [Phase 2]
Phase 2 study evaluating the efficacy and safety of daglutril vs placebo added to losartan in adults with type 2 diabetes, overt nephropathy…
-
FDA approval · 2007-11-13FDA Approved: CARVEDILOL — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's supplemental application for carvedilol, indicating an approved labeling change for the drug.
-
FDA approval · 2007-11-13FDA Approved: CAPTOPRIL — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' supplemental application for CAPTOPRIL (captopril), approving an additional change to the approved ANDA…
-
CLINICAL_TRIALS trial_result · 2007-11-08Clinical Trial Update: Higher Dose of Ramipril Versus Addition of Telmisartan-Ramipril in Hypertension and Diabetes [Phase 3]
A Phase 3 trial comparing a higher dose of ramipril to the addition of telmisartan-ramipril in hypertension with type 2 diabetes was termina…
-
CLINICAL_TRIALS research · 2007-11-06Clinical Trial Update: Does Aldosterone Cause Hypertension by a Non-Renal Mechanism? [Phase 4]
This Phase 4 clinical trial update discusses whether aldosterone can cause hypertension through non-renal mechanisms, with the current statu…
-
FDA approval · 2007-11-01FDA Approved: TRIAMTERENE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for Triamterene and Hydrochlorothiazide from Sandoz Inc. This action approves a supplement to the or…
-
FDA label_change · 2007-10-31FDA Approved: NORVASC — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for NORVASC (amlodipine besylate) by Viatris Specialty LLC, resulting in changes to the labeling…
-
FDA approval · 2007-10-31FDA Approved: ATENOLOL — Original Application (Aurobindo Pharma Limited)
FDA approved Atenolol from Aurobindo Pharma Limited under an Original Application (ANDA) for a generic beta-blocker.
-
CLINICAL_TRIALS trial_result · 2007-10-30Clinical Trial Update: Phase IIa Safety and Efficacy Study of SPP635 in Mild to Moderate Hypertension [Phase 2]
Phase IIa safety and efficacy study of SPP635 for mild to moderate hypertension has completed.
-
FDA approval · 2007-10-25FDA Approved: CARVEDILOL — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for carvedilol from Quallent Pharmaceuticals Health LLC to market a generic version of the drug.
-
CLINICAL_TRIALS trial_result · 2007-10-25Clinical Trial Update: Tadalafil in Subjects With Mild to Moderate Hypertension [Phase 2]
A Phase 2 trial evaluating tadalafil in adults with mild to moderate hypertension has been completed. The study was sponsored by Eli Lilly a…
-
CLINICAL_TRIALS trial_result · 2007-10-25Clinical Trial Update: Irbesartan Effects on Endothelial Dysfunction in Hypertensive Type II Diabetic Patients Comparing Atenolol [Phase 4]
Phase 4 clinical trial update evaluating the effects of irbesartan on endothelial dysfunction in hypertensive patients with type 2 diabetes,…
-
FDA approval · 2007-10-23FDA Approved: QUINAPRIL — Supplemental Application (BluePoint Laboratories)
The FDA approved a supplemental application for Quinapril submitted by BluePoint Laboratories. This approval updates the existing Quinapril …
-
CLINICAL_TRIALS research · 2007-10-23Clinical Trial Update: Intensive Medical Treatment for Nephropathy Caused by Type 2 Diabetes With Hypertension [Phase 4]
Clinical trial update on a Phase 4 study evaluating intensive medical treatment for nephropathy caused by Type 2 Diabetes Mellitus in patien…